Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-47,818
Closed -$460K – 646
2023
Q1
$460K Sell
47,818
-15,981
-25% -$177K 0.02% 331
2022
Q4
$710K Buy
63,799
+36,860
+137% +$385K 0.02% 267
2022
Q3
$230K Sell
26,939
-85,509
-76% -$842K 0.01% 450
2022
Q2
$1.18M Buy
112,448
+66,515
+145% +$729K 0.04% 177
2022
Q1
$500K Buy
+45,933
New +$605K 0.02% 291
2021
Q4
– Sell
-29,972
Closed -$406K – 462
2021
Q3
$406K Buy
+29,972
New +$425K 0.02% 146
2020
Q3
– Sell
-174
Closed -$3K – 829
2020
Q2
$3K Buy
174
+7
+4% +$113 ﹤0.01% 817
2020
Q1
$2K Buy
167
+5
+3% +$96 ﹤0.01% 591
2019
Q4
$3K Sell
162
-38
-19% -$707 ﹤0.01% 516
2019
Q3
$4K Buy
+200
New +$3.92K ﹤0.01% 593
2019
Q2
– Sell
-324
Closed -$9K – 768
2019
Q1
$9K Buy
+324
New +$9.45K ﹤0.01% 276

Other funds holding VTRS

Balentine LLC's VTRS Position: Q2 2023 in Review

Balentine LLC sold out of Viatris (VTRS) in Q2 2023, closing a stake of 47,818 shares — an estimated $460K sold.

Balentine LLC first reported a position in VTRS in Q1 2019 and held it in 11 quarters. The position peaked at $1.18M in Q2 2022. 987 funds tracked by Wall St. Rank hold VTRS as of Q2 2023.

  • Balentine LLC reported no remaining Viatris position as of Q2 2023 after selling out during the quarter.
  • Balentine LLC sold 47,818 Viatris shares in Q2 2023, an estimated $460K.
  • Balentine LLC first reported a position in Viatris in Q1 2019 and held it in 11 quarters.
  • Balentine LLC's Viatris position peaked at $1.18M in Q2 2022.
  • 987 funds tracked by Wall St. Rank held Viatris as of Q2 2023.

Based on Balentine LLC's 13F filing for Q2 2023, filed 14 Aug 2023.